Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
Thomas GrüterJeremias MotteYesim BulutAnna KordesDiamantis AthanasopoulosMiriam FelsChristiane Schneider-GoldRalf GoldAnna Lena FisseKalliopi PitarokoiliPublished in: European journal of neurology (2021)
Total disability is largely determined by the degree of axonal damage, especially in typical CIDP. Although most patients have symptoms predominantly in the legs, NCS of the upper limbs are essential for the monitoring of patients with CIDP and CIDP variants.